Novo Q4: Sigter over analytikernes prognose for 2022 - NY
https://www.proinvestor.com/investornyt/774806/novo-q4-sigter-over-analytikernes-prognose-for-2022-ny

]]>https://dev.proinvestor.com/forum/topic/400859/pharma-februar-2022RSS for NodeSun, 07 Jun 2026 02:39:10 GMTWed, 02 Feb 2022 06:04:46 GMT60Novo/Berenberg: Kursmål hæves til 585 kr. fra 530 kr. https://proinvestor.com/investornyt/788113/novo-berenberg-kursmal-haeves-til-585-kr-fra-530-kr

]]>https://dev.proinvestor.com/forum/post/8037573https://dev.proinvestor.com/forum/post/8037573Mon, 28 Feb 2022 05:55:47 GMTNovo har nu nok Wegovy til alle med recept i USA - NY https://proinvestor.com/investornyt/786446/novo-har-nu-nok-wegovy-til-alle-med-recept-i-usa-ny

]]>https://dev.proinvestor.com/forum/post/8037574https://dev.proinvestor.com/forum/post/8037574Thu, 24 Feb 2022 10:11:32 GMTNovo: Blackrock går under 5 pct. https://proinvestor.com/investornyt/784813/novo-blackrock-gar-under-5-pct

]]>https://dev.proinvestor.com/forum/post/8037571https://dev.proinvestor.com/forum/post/8037571Mon, 21 Feb 2022 15:03:19 GMTHenrik Poulsen står til at avancere i Novo Nordisks bestyrelse - NY https://proinvestor.com/investornyt/784780/henrik-poulsen-star-til-at-avancere-i-novo-nordisks-bestyrelse-ny

]]>https://dev.proinvestor.com/forum/post/8037575https://dev.proinvestor.com/forum/post/8037575Mon, 21 Feb 2022 15:01:57 GMTALK-Abelló foreslår Alan Main til bestyrelsen https://proinvestor.com/investornyt/784774/alk-abello-foreslar-alan-main-til-bestyrelsen

]]>https://dev.proinvestor.com/forum/post/8037570https://dev.proinvestor.com/forum/post/8037570Mon, 21 Feb 2022 15:01:07 GMTALK-Abelló vil splitte aktien i 20 - NY https://proinvestor.com/investornyt/784768/alk-abello-vil-splitte-aktien-i-20-ny

]]>https://dev.proinvestor.com/forum/post/8037569https://dev.proinvestor.com/forum/post/8037569Mon, 21 Feb 2022 13:30:07 GMTLundbeck: Svensk erhvervsavis ser muligheder https://proinvestor.com/investornyt/784693/lundbeck-svensk-erhvervsavis-ser-muligheder

]]>https://dev.proinvestor.com/forum/post/8037572https://dev.proinvestor.com/forum/post/8037572Mon, 21 Feb 2022 09:53:29 GMTNovo: Amerikansk salgsdirektør skifter til Leo Pharma https://proinvestor.com/investornyt/783412/novo-amerikansk-salgsdirektor-skifter-til-leo-pharma

]]>https://dev.proinvestor.com/forum/post/8037568https://dev.proinvestor.com/forum/post/8037568Thu, 17 Feb 2022 15:13:55 GMTBuffett, Teva: Warren har mistet tålmodigheden https://proinvestor.com/index.php?p=debat_1&postid=101086

]]>https://dev.proinvestor.com/forum/post/8037576https://dev.proinvestor.com/forum/post/8037576Tue, 15 Feb 2022 06:33:33 GMTALK/Jefferies: Kursmål sænkes over 12 pct. til 2650 kr. https://proinvestor.com/investornyt/781620/alk-jefferies-kursmal-saenkes-over-12-pct-til-2650-kr

]]>https://dev.proinvestor.com/forum/post/8037567https://dev.proinvestor.com/forum/post/8037567Tue, 15 Feb 2022 05:05:51 GMTNovo Nordisk: Blackrock øger aktiepost til over 5 pct. https://proinvestor.com/investornyt/781113/novo-nordisk-blackrock-oger-aktiepost-til-over-5-pct

]]>https://dev.proinvestor.com/forum/post/8037566https://dev.proinvestor.com/forum/post/8037566Mon, 14 Feb 2022 11:05:21 GMTLundbeck langer ud efter amerikanske selskaber i patentslagsmål https://proinvestor.com/investornyt/781065/lundbeck-langer-ud-efter-amerikanske-selskaber-i-patentslagsmal

]]>https://dev.proinvestor.com/forum/post/8037564https://dev.proinvestor.com/forum/post/8037564Mon, 14 Feb 2022 07:39:25 GMTHere's How Healthcare Stocks Have Historically Performed After a Down January https://www.proinvestor.com/investornyt/780839/heres-how-healthcare-stocks-have-historically-performed-after-a-down-january

]]>https://dev.proinvestor.com/forum/post/8037565https://dev.proinvestor.com/forum/post/8037565Sat, 12 Feb 2022 12:01:14 GMTLundbeck/DNB: Kursmål sænkes til 200 kr. fra 215 kr. https://proinvestor.com/investornyt/779414/lundbeck-dnb-kursmal-saenkes-til-200-kr-fra-215-kr

]]>https://dev.proinvestor.com/forum/post/8037562https://dev.proinvestor.com/forum/post/8037562Thu, 10 Feb 2022 07:37:45 GMTLundbeck/SVB: Kursmål sænkes til 175 kr. fra 200 kr. https://proinvestor.com/investornyt/779372/lundbeck-svb-kursmal-saenkes-til-175-kr-fra-200-kr

]]>https://dev.proinvestor.com/forum/post/8037561https://dev.proinvestor.com/forum/post/8037561Thu, 10 Feb 2022 05:02:51 GMTLundbeck Q4: Gevaldig skuffelse over hele linjen - NY https://www.proinvestor.com/investornyt/778654/lundbeck-q4-gevaldig-skuffelse-over-hele-linjen-ny

]]>https://dev.proinvestor.com/forum/post/8037556https://dev.proinvestor.com/forum/post/8037556Wed, 09 Feb 2022 06:22:39 GMTLundbeck Q4: Nøgleprodukterne skuffer https://www.proinvestor.com/investornyt/778646/lundbeck-q4-nogleprodukterne-skuffer

]]>https://dev.proinvestor.com/forum/post/8037559https://dev.proinvestor.com/forum/post/8037559Wed, 09 Feb 2022 06:08:34 GMTLundbeck laver ny aktiestruktur - deler op i A- og B-aktier - NY https://www.proinvestor.com/investornyt/778641/lundbeck-laver-ny-aktiestruktur-deler-op-i-a-og-b-aktier-ny

]]>https://dev.proinvestor.com/forum/post/8037563https://dev.proinvestor.com/forum/post/8037563Wed, 09 Feb 2022 05:49:24 GMTALK/Sydbank: Har stærk vækst ikke mindst i tabletsalget https://proinvestor.com/investornyt/777918/alk-sydbank-har-staerk-vaekst-ikke-mindst-i-tabletsalget

]]>https://dev.proinvestor.com/forum/post/8037560https://dev.proinvestor.com/forum/post/8037560Tue, 08 Feb 2022 08:15:16 GMTALK/CEO: Leverer rekordresultater trods udfordringer med corona - NY https://proinvestor.com/investornyt/777913/alk-ceo-leverer-rekordresultater-trods-udfordringer-med-corona-ny

]]>https://dev.proinvestor.com/forum/post/8037554https://dev.proinvestor.com/forum/post/8037554Tue, 08 Feb 2022 07:43:31 GMTALK-Abelló OVERBLIK Q4: Tabletsalget overgår forventningerne https://proinvestor.com/investornyt/777902/alk-abello-overblik-q4-tabletsalget-overgar-forventningerne

]]>https://dev.proinvestor.com/forum/post/8037558https://dev.proinvestor.com/forum/post/8037558Tue, 08 Feb 2022 06:19:48 GMTSanofi : FDA Approves Enjaymo, First Treatment For Use In Patients With Cold Agglutinin Disease https://www.proinvestor.com/investornyt/777139/sanofi-fda-approves-enjaymo-first-treatment-for-use-in-patients-with-cold-agglutinin-disease

]]>https://dev.proinvestor.com/forum/post/8037552https://dev.proinvestor.com/forum/post/8037552Sun, 06 Feb 2022 07:09:26 GMTNovo Nordisk: Topledelse sælger ud efter tildelelse af aktier https://proinvestor.com/investornyt/776726/novo-nordisk-topledelse-saelger-ud-efter-tildelelse-af-aktier

]]>https://dev.proinvestor.com/forum/post/8037549https://dev.proinvestor.com/forum/post/8037549Fri, 04 Feb 2022 14:54:03 GMTSanofi Q4 Profit Rises; Sees 2022 Business EPS Growth To Be Low Double-digit At CERhttps://www.proinvestor.com/investornyt/776461/sanofi-q4-profit-rises-sees-2022-business-eps-growth-to-be-low-double-digit-at-cer

]]>https://dev.proinvestor.com/forum/post/8037557https://dev.proinvestor.com/forum/post/8037557Fri, 04 Feb 2022 06:26:04 GMT